L23. Renal transplantation in ANCA-associated vasculitis

Presse Medicale

Volumn 42, Issue 4 PART2, 2013, Pages 568-571

  Segelmark, Mårten ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; RITUXIMAB;

AFRICAN AMERICAN; ANCA ASSOCIATED VASCULITIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; RELAPSE; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875597148     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.01.023     Document Type: Letter

References (29)

1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341(23):1725-1730. [Comparative Study Research Support, U.S. Gov't, P.H.S.].
2. Nachman P.H., Hogan S.L., Jennette J.C., Falk R.J. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996, 7(1):33-39.
3. Elmedhem A., Adu D., Savage C.O. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003, 18(5):1001-1004. [Research Support, Non-U.S. Gov't].
4. Nachman P.H., Segelmark M., Westman K., Hogan S.L., Satterly K.K., Jennette J.C., et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 1999, 56(4):1544-1550.
5. Nyberg G., Akesson P., Norden G., Wieslander J. Systemic vasculitis in a kidney transplant population. Transplantation 1997, 63(9):1273-1277.
6. Geetha D., Eirin A., True K., Valentina Irazabal M., Specks U., Seo P., et al. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience. Transplantation 2011, 91(12):1370-1375. [Multicenter Study].
7. Schmitt W.H., van der Woude F.J. Organ transplantation in the vasculitides. Curr Opin Rheumatol 2003, 15(1):22-28. [Review].
8. Haubitz M., Kliem V., Koch K.M., Nashan B., Schlitt H.J., Pichlmayr R., et al. Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Transplantation 1997, 63(9):1251-1257.
9. Allen A., Pusey C., Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998, 9(7):1258-1263. [Comparative Study Research Support, Non-U.S. Gov't].
10. Little M.A., Hassan B., Jacques S., Game D., Salisbury E., Courtney A.E., et al. Renal transplantation in systemic vasculitis: when is it safe?. Nephrol Dial Transplant 2009, 24(10):3219-3225. [Research Support, Non-U.S. Gov't].
11. Schmitt W.H., Haubitz M., Mistry N., Brunkhorst R., Erbsloh-Moller B., Gross W.L. Renal transplantation in Wegener's granulomatosis. Lancet 1993, 342(8875):860.
12. Rostaing L., Modesto A., Oksman F., Cisterne J.M., Le Mao G., Durand D. Outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 1997, 29(1):96-102. [Case Reports Comparative Study].
13. Basu N., Watts R., Bajema I., Baslund B., Bley T., Boers M., et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010, 69(10):1744-1750. [Consensus Development Conference Research Support, Non-U.S. Gov't].
14. Weidemann S., Andrassy K., Ritz E. ANCA in haemodialysis patients. Nephrol Dial Transplant 1993, 8(9):839-845.
15. Watts R.A., Lane S.E., Scott D.G., Koldingsnes W., Nossent H., Gonzalez-Gay M.A., et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001, 60(12):1156-1157.
16. Mohammad A.J., Jacobsson L.T., Westman K.W., Sturfelt G., Segelmark M. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009, 48(12):1560-1565.
17. Ormerod A.S., Cook M.C. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 2008, 38(11):816-823. [Comparative Study].
18. Cao Y., Schmitz J.L., Yang J., Hogan S.L., Bunch D., Hu Y., et al. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol 2011, 22(6):1161-1167. [Research Support, N.I.H., Extramural].
19. Watts R.A., Scott D.G., Jayne D.R., Ito-Ihara T., Muso E., Fujimoto S., et al. Renal vasculitis in Japan and the UK: are there differences in epidemiology and clinical phenotype?. Nephrol Dial Transplant 2008, 23(12):3928-3931.
20. Booth A.D., Almond M.K., Burns A., Ellis P., Gaskin G., Neild G.H., et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003, 41(4):776-784.
21. Walsh M., Flossmann O., Berden A., Westman K., Hoglund P., Stegeman C., et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012, 64(2):542-548. [Research Support, Non-U.S. Gov't].
22. Steinman T.I., Jaffe B.F., Monaco A.P., Wolff S.M., Fauci A.S. Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. Am J Med 1980, 68(3):458-460. [Case Reports].
23. Merino J.L., Galeano C., Espejo B., Rivera M., Fernandez-Lucas M., Caldes S., et al. A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy. Nephrol Dial Transplant 2011, 26(4):1360-1366.
24. Nowack R., Grab I., Flores-Suarez L.F., Schnulle P., Yard B., van der Woude F.J. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2001, 16(8):1631-1637.
25. Sanders J.S., Huitma M.G., Kallenberg C.G., Stegeman C.A. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 2006, 45(6):724-729.
26. Segelmark M., Phillips B.D., Hogan S.L., Falk R.J., Jennette J.C. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clin Diagn Lab Immunol 2003, 10(5):769-774.
27. Geetha D., Seo P., Specks U., Fervenza F.C. Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases. Am J Transplant 2007, 7(12):2821-2825. [Case Reports Research Support, Non-U.S. Gov't].
28. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
29. Rama I., Grinyo J.M. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol 2010, 6(9):511-519. [Review].